Your email has been successfully added to our mailing list.

×
5.81395348838436E-05 5.81395348838436E-05 -0.00901162790697665 -0.00581395348837197 -0.00290697674418598 -0.0406976744186046 -0.0580813953488371 -0.0584883720930231
Stock impact report

Myriad's Ovarian Cancer Test Approved, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]

TETRAPHASE PHARMACEUTICALS INC (TTPH) 
Last tetraphase pharmaceuticals inc earnings: 3/11 09:29 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.tphase.com/investor-relations
Company Research Source: Seeking Alpha
SummaryMyriad's ovarian cancer test has been approved by the FDA.MyoKardia reports positive phase 3 data.ACRX reports earnings.Myriad Receives the FDA Approval for Testing Ovarian CancerMyriad Genetics (MYGNThis test is particularly aimed at patients suffering from ovarian cancer with positive homologous recombination deficiency (HRD) status. HRD refers to either genomic instability or a deleterious or suspected deleterious BRCA mutation in patients who have progressed for more than six months after responding to platinum-based chemo. Nicole Lambert, president of Myriad Oncology and Women’s HealthsaidmyChoice CDx test works by carrying out tumor sequencing of the BRCA1 and BRCA2 genes and a composite of three proprietary technologies. These three technologies pertain to loss of heterozygosity, telomeric allelic imbalance and large-scale state transitions. The test will enable the company in boosting its foothold in a lucrative market. Ovarian cancer is the eighth most common cause of Show less Read more
Impact Snapshot
Event Time:
TTPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for TTPH alerts
Opt-in for
TTPH alerts

from News Quantified
Opt-in for
TTPH alerts

from News Quantified